M&A Deal Summary

Trinity Biotech Acquires Metabolomic Diagnostics

On September 24, 2024, Trinity Biotech acquired life science company Metabolomic Diagnostics

Acquisition Highlights
  • This is Trinity Biotech’s 3rd transaction in the Life Science sector.
  • This is Trinity Biotech’s 2nd transaction in Ireland.

M&A Deal Summary
Date 2024-09-24
Target Metabolomic Diagnostics
Sector Life Science
Buyer(s) Trinity Biotech
Deal Type Add-on Acquisition

Target

Metabolomic Diagnostics

Co. Cork, Ireland
Metabolomic Diagnostics is an Irish deep-tech company, specializing in the development of novel biomarker-based diagnostic solutions for complex diseases. Metabolomic Diagnostics is based in Co. Cork, Ireland.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Trinity Biotech

Bray, Ireland
Category Company
Founded 1992
Sector Healthcare Services
Employees380
Revenue 57M USD (2023)
DESCRIPTION

Trinity Biotech is an entity acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. Trinity Biotech was founded in 1992 and is based in Bray, Ireland.

DEAL STATS #
Overall 8 of 9
Sector (Life Science) 3 of 4
Type (Add-on Acquisition) 5 of 6
Country (Ireland) 2 of 3
Year (2024) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-09-24 Metabolomics Diagnostics

Cork, Ireland

Metabolomics Diagnostics is specialized in the development of novel biomarker-based diagnostic solutions for complex diseases. Metabolomics Diagnostics is based in Cork, Ireland.

Buy $1M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-25 EpiCapture

Dublin, Ireland

EpiCapture is a company developing a non-invasive test for monitoring the risk of aggressive prostate cancer. EpiCapture is based in Dublin, Ireland.

Buy $3M
Mergr

Product

Company

Legal